Prikaz rezultata 1 – 1 od 1 za pretragu 'for the PRESS XII study group', vrijeme upita: 0,02s Detaljiziraj rezultate
  1. 1
    Effect of saroglitazar 2 mg and 4 mg on glycemic control, lipid profile and cardiovascular disease risk in patients with type 2 diabetes mellitus: a 56-week, randomized, double blind, phase 3 study (PRESS XII study)

    Effect of saroglitazar 2 mg and 4 mg on glycemic control, lipid profile and cardiovascular disease risk in patients with type 2 diabetes mellitus: a 56-week, randomized, double bli... od Manjunath Krishnappa, Kishor Patil, Krupi Parmar, Purav Trivedi, Nirali Mody, Chintan Shah, Khushboo Faldu, Sanjay Maroo, for the PRESS XII study group, Deven Parmar

    Izdano 2020-06-01
    Preuzmi cijeli tekst
    Članak

Alati za pretragu: